P+P advises Middle Peak Medical on sale to Symetis
Founded in 2001, Symetis is a Swiss medical technology company, which specializes in the development, production and marketing of next generation percutaneous heart valve replacement solutions for the treatment of serious heart valve diseases.
Middle Peak Medical is a private US and German company specializing in the development of minimally invasive innovative solutions for unmet medical needs in the treatment of mitral regurgitation.
With the acquisition, Symetis is expanding from the TAVI division into the broader segment of structural heart diseases.
P+P Pöllath + Partners comprehensively advised Middle Peak Medical GmbH and its shareholders on the sale of their shares in Middle Peak Medical GmbH to Symetis SA on all aspects of German law with the following team:
- Dr. Michael Inhester (partner, M&A, Munich)
- Adalbert Makos (senior associate, M&A, Munich)
- Eva-Juliane Stark, LL.M. (M&A, Berlin)
